Connor, Clark & Lunn Investment Management Ltd. Biote Corp. Call Options Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $26 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BTMD
# of Institutions
97Shares Held
16.4MCall Options Held
0Put Options Held
0-
325 Capital LLC New York, NY4.55MShares$14 Million8.28% of portfolio
-
Bandera Partners LLC New York, NY2.28MShares$7.01 Million4.11% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$4.93 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.42MShares$4.37 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA685KShares$2.1 Million0.01% of portfolio
About biote Corp.
- Ticker BTMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 7,574,270
- Market Cap $23.3M
- Description
- biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...